ONE OF THE MOST UNIQUE ASPECTS OF GEN 5 FERTILITY IS ITS EMPHASIS ON RESEARCH.
While most fertility centers focus only on what other researchers think are the current (or past) “best” treatment strategies, we focus on improving the outcomes of all infertility patients, both those who receive care from us and those who must receive their care elsewhere.
One of the most important areas of research in reproductive medicine today is the use of PRP or EPF for Ovarian Rejuvenation. PRP is short for Platelet Rich Plasma Therapy and ERF is the abbreviation for Enriched Platelet Factors ( including EnPLAF). These two therapies are similar but also have significant differences. Please see our detailed webpage about Ovarian Rejuvenation for more information.
Over the past two years, the clinical staff at Gen 5 Fertility has published several scientific papers about PRP / EnPLAF. Additional papers have been accepted or are being considered for publication at the present time. Below are PDF versions of some of these.
Click to see one of the most important of our recent publications, one that provides the logical thinking and some of the prior research that explains how platelet derived growth factors may serve to rejuvenate the ovaries. It’s not an easy read. But, because it provides many of the details behind these procedures, it may be worth the effort.
Gen 5 Fertility Creates the Future of ReproductiveMedicine.
Sills ES, Rickers NS, Wood SH. (2020) Intraovarian insertion of autologous platelet growth factors as cell-free concentrate: Fertility recovery and first unassisted conception with term delivery at age over 40. Int J Reprod BioMed 2020;18(12):1081-1086. http://dx.doi.org/10.18502/ijrm.v18i12.8030
Sills ES, Wood SH. (2020). An experimental model for peri-conceptual COVID-19 pregnancy loss and proposed interventions to optimize outcomes. Int J Mol Cell Med 2020;9(3):1-8. http://dx.doi.org/10.22088/IJMCM.BUMS.9.3.180
Wood SH, Sills, ES. (2020). Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes. Clinical and Experimental Reproductive Medicine, 10.5653/cerm.2019.03405. https://doi.org/10.5653/cerm.2019.03405
Sills ES, Rickers NS, Peterson JL, Xiang Li, Wood SH. (2020) Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients. Intl J Regen Med 2020;3(1):1-5
Sills, E. S., & Wood, S. H. (2019). Autologous Activated Platelet-Rich Plasma Injection into Adult Human Ovary Tissue: Molecular Mechanism, Analysis, and Discussion of Reproductive Response. Bioscience reports, 39(6), BSR20190805. https://doi.org/10.1042/BSR20190805
Sills, E. S., Li, X., Rickers, N. S., Wood, S. H., & Palermo, G. D. (2019). Metabolic and Neurobehavioral Response Rollowing Intraovarian Administration of Autologous Activated Platelet Rich Plasma: First Qualitative data. Neuro Endocrinology Letters, 39(6), 427–433.
Sills, E. S., Rickers, N. S., Li, X., & Palermo, G. D. (2018). First Data on In Vitro Fertilization and Blastocyst Formation After Intraovarian Injection of Calcium Gluconate-Activated Autologous Platelet Rich Plasma. Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology, 34(9), 756–760. https://doi.org/10.1080/09513590.2018.1445219
Sills, E. S., Anderson, R. E., McCaffrey, M., Li, X., Arrach, N., & Wood, S. H. (2016). Gestational Surrogacy and the Role of Routine Embryo Screening: Current Challenges and Future Directions for Preimplantation Genetic Testing. Birth Defects Research. Part C, Embryo Today : reviews, 108(1), 98–102. https://doi.org/10.1002/bdrc.21112
Get In Touch
3420 Carmel Mountain Rd Ste 200 San Diego, CA 92121
For Patient Inquires
Call-in hours are M-F, 9 a.m. – 4 p.m.
May vary due to Covid-19
Copyright © 2020 Gen5Fertility. All Rights Reserved.